Abstract
Allosteric interactions between transmembrane G protein-coupled receptors (GPCRs) could lead to conformational changes and therefore oligomer function diversity increase. GPCR complexes are composed by homo- or heteroreceptors that can further assemble into receptor mosaic. These allosteric interactions could play a major role in brain regulation and plasticity. Alteration in GPCR neuromodulation may be involved in depression, schizophrenia, and addiction. Several studies reported that activation of the D4 dopaminergic receptor blocks many of the molecular, cellular, and behavioral effects produced by morphine. The existence of a MOR/D4R allosteric interaction through orthosteric agonist might lead to a secure therapeutic use of morphine. Here we describe the co-immunoprecipitation technique to study direct GPCR interaction in cell culture.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fredriksson R, Lagerström MC, Lundin L-G, Schiöth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256–1272. https://doi.org/10.1124/mol.63.6.1256
Agnati LF, Fuxe K, Zoli M et al (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med Biol 60:183–190
Fuxe K, Agnati LF, Benfenati F et al (1983) Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J Neural Transm Suppl 18:165–179
Fuxe K, Borroto-Escuela DO (2016) Heteroreceptor complexes and their allosteric receptor–receptor interactions as a novel biological principle for integration of communication in the CNS: targets for drug development. Neuropsychopharmacology 41:380–382. https://doi.org/10.1038/npp.2015.244
Han Y, Moreira IS, Urizar E et al (2009) Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 5:688–695. https://doi.org/10.1038/nchembio.199
Farran B (2017) An update on the physiological and therapeutic relevance of GPCR oligomers. Pharmacol Res 117:303–327. https://doi.org/10.1016/j.phrs.2017.01.008
Fuxe K, Dahlström AB, Jonsson G et al (2010) The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 90:82–100. https://doi.org/10.1016/j.pneurobio.2009.10.012
Borroto-Escuela DO, Carlsson J, Ambrogini P et al (2017) Understanding the role of GPCR heteroreceptor complexes in modulating the brain networks in health and disease. Front Cell Neurosci 11:1–20. https://doi.org/10.3389/fncel.2017.00037
Rivera A, Gago B, Suárez-Boomgaard D et al (2017) Dopamine D4 receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction. Addict Biol 22(5):1232–1245. https://doi.org/10.1111/adb.12407
Gago B, Fuxe K, Agnati L et al (2007) Dopamine D(4) receptor activation decreases the expression of mu-opioid receptors in the rat striatum. J Comp Neurol 502:358–366. https://doi.org/10.1002/cne.21327
Gago B, Suárez-Boomgaard D, Fuxe K et al (2011) Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. Brain Res 1407:47–61. https://doi.org/10.1016/j.brainres.2011.06.046
Gago B, Fuxe K, Brené S et al (2013) Early modulation by the dopamine D4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen. J Neurosci Res 91:1533–1540. https://doi.org/10.1002/jnr.23277
Suárez-Boomgaard D, Gago B, Valderrama-Carvajal A et al (2014) Dopamine D4 receptor counteracts morphine-induced changes in μ-opioid receptor signaling in the striosomes of the rat caudate putamen. Int J Mol Sci 15:1481–1498. https://doi.org/10.3390/ijms15011481
Arvidsson U, Riedl M, Chakrabarti S et al (1995) Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328–3341
Rivera A, Cuéllar B, Girón FJ et al (2002) Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 80:219–229. https://doi.org/10.1046/j.0022-3042.2001.00702.x
Rivera A, Trías S, Peñafiel A et al (2003) Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res 989:35–41. https://doi.org/10.1016/S0006-8993(03)03328-6
Fuxe K, Marcellino D, Rivera A et al (2008) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 58:415–452. https://doi.org/10.1016/j.brainresrev.2007.11.007
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Shumilov, K., Valderrama-Carvajal, A., García-Bonilla, M., Rivera, A. (2019). Co-immunoprecipitation as a Useful Tool for Detection of G Protein-Coupled Receptor Oligomers. In: Odagaki, Y., Borroto-Escuela, D. (eds) Co-Immunoprecipitation Methods for Brain Tissue . Neuromethods, vol 144. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8985-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8985-0_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8984-3
Online ISBN: 978-1-4939-8985-0
eBook Packages: Springer Protocols